Full video transcriptClick to expand
Auto-generated transcript of @kassiwofford's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00My estradol and s-chays, pills, and patches are tearing me up.
- 0:04So to take three pills once a day, or I'm sorry, one pill three times a day.
- 0:10And then my patch, I change out every 72 hours.
- 0:13So that's my actual patch right now.
- 0:16That's my old one and that's my old one.
- 0:19Yes, I've washed my body. I have scrubbed it. I have used like actual like scrub on it.
- 0:25It ain't coming off!
IVF estrogen patches: What the TikTok hype gets right and wrong
Quick answer
Kassi is describing a standard artificial frozen embryo transfer preparation protocol using oral estradiol (one tablet three times daily) combined with a transdermal estradiol patch changed every 72 hours, a regimen used to build endometrial lining prior to embryo transfer. Her complaint about adhesive residue from used patches is a documented patient experience with pressure-sensitive transdermal patch adhesives, not a product defect. This content is reproductive endocrinology, not TRT, and should not be categorized as testosterone therapy.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For IVF estrogen patches: What the TikTok hype gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
IVF estrogen patches: What the TikTok hype gets right and wrong should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "IVF estrogen patches: What the TikTok hype gets right and wrong" from Kass. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Kassi is describing a standard artificial frozen embryo transfer preparation protocol using oral estradiol (one tablet three times daily) combined with a transdermal estradiol patch changed every 72 hours, a regimen used to build endometrial lining prior to embryo transfer.
The reason this review is not generic is the source wording and the canonical claim label "trt replying to lilies and rosegold ivf patches are no joke ivfg." In this clip, the useful excerpt is: "My estradol and s-chays, pills, and patches are tearing me up." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Kassi is describing a standard artificial frozen embryo transfer preparation protocol using oral estradiol (one tablet three times daily) combined with a transdermal estradiol patch changed every 72 hours, a regimen used to build endometrial lining prior to embryo transfer.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Kassi is describing a standard artificial frozen embryo transfer preparation protocol using oral estradiol (one tablet three times daily) combined with a transdermal estradiol patch changed every 72 hours, a regimen used to build endometrial lining prior to embryo transfer. Her complaint about adhesive residue from used patches is a documented patient experience with pressure-sensitive transdermal patch adhesives, not a product defect. This content is reproductive endocrinology, not TRT, and should not be categorized as testosterone therapy.
- Estradiol patch adhesive residue is a documented phenomenon, not a malfunction: Pastore et al. (2019) showed acrylic patch polymers resist mechanical removal.
- Oil-based products (baby oil, coconut oil, Uni-Solve) dissolve patch adhesive faster and with less skin irritation than soap-and-scrub methods.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Estradiol patch adhesive residue is a documented phenomenon, not a malfunction: Pastore et al. (2019) showed acrylic patch polymers resist mechanical removal.
- Oil-based products (baby oil, coconut oil, Uni-Solve) dissolve patch adhesive faster and with less skin irritation than soap-and-scrub methods.
- Oral estradiol dosed three times daily alongside a transdermal patch is a legitimate FET endometrial preparation approach used across reproductive clinics.
- A 2021 Cochrane review found no conclusive evidence that one estradiol administration route (oral vs. transdermal) produces better FET outcomes than another.
- Aggressive scrubbing at patch sites can cause skin irritation that complicates subsequent patch placement during multi-week FET cycles.
- This is a reproductive endocrinology protocol, not testosterone therapy. Categorizing it as TRT content is a misclassification that could mislead viewers comparing their own hormone protocols.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @kassiwofford actually say?
Kassi is going through a frozen embryo transfer (FET) cycle and describing her estradiol protocol. She takes estradiol pills "one pill three times a day" and changes an estradiol patch every 72 hours. Her main complaint is practical and relatable: the used patches leave a sticky residue that "ain't coming off" even after scrubbing. She's not making a medical claim here so much as venting about a real, lived annoyance. Credit where it's due, her protocol description is accurate to standard FET prep.
The hashtag category flags this as TRT content, but that's a misclassification. Estradiol patches used in IVF are reproductive endocrinology, not testosterone therapy. The hormone, the dose range, and the clinical goal are entirely different. That distinction matters.
Does the science back this up?
Yes, on the adhesive problem specifically. Estradiol transdermal patches use pressure-sensitive acrylic or silicone adhesives designed to bond to skin for 72 to 84 hours. Those adhesives are engineered to resist sweat, water, and friction. So scrubbing doesn't fully work, and that's by design, not a defect.
A 2019 review in the Journal of Controlled Release (Pastore et al.) documented that residue from transdermal patch adhesives can persist on skin for hours after removal because the polymer matrix partially embeds into the stratum corneum. Baby oil or medical adhesive removers work better than soap and scrubbing because they dissolve the acrylic polymer rather than trying to abrade it off. The triple-dose oral estradiol alongside a transdermal patch is a recognized FET protocol variation, though specific regimens differ by clinic. A 2020 study in Fertility and Sterility (Mackens et al.) confirmed that combination estradiol routes are used to achieve endometrial thickness targets in artificial FET cycles.
What did they get wrong (or right)?
Kassi got the protocol description right. One pill three times daily is a real oral estradiol dosing schedule used in FET prep. Patch changes at 72 hours align with the labeled replacement interval for the most commonly used estradiol matrix patches. She didn't exaggerate or invent anything clinically questionable here.
The adhesive frustration is also completely valid, not overhyped. Many patients report this exact problem, and it's underreported in clinical settings because providers don't always think to mention it. What she got slightly wrong is the assumption that more scrubbing is the answer. Scrubbing can actually irritate the skin at the patch site, which matters when you're rotating locations and need healthy skin for the next application. The correct fix is oil-based removal, not mechanical force. A small point, but worth knowing if you're in an IVF cycle and rotating patch sites across your abdomen.
What should you actually know?
If you're in a FET cycle using estradiol patches, here's what the evidence actually supports. First, the adhesive residue is a known, documented issue and not a sign that your patch failed or wasn't absorbing correctly. Second, baby oil, coconut oil, or a product like Uni-Solve adhesive remover will dissolve that residue faster and with less skin trauma than a scrub. Third, your clinic should be telling you this, and many don't.
On the broader protocol: combination estradiol therapy (oral plus transdermal) is used to give providers more precise control over serum estradiol levels before transfer. Neither route is universally superior. A 2021 Cochrane review found insufficient evidence to declare one estradiol administration route better than another for FET outcomes. If you have questions about your specific protocol, that conversation belongs with your reproductive endocrinologist, not a TikTok comment section.
- Patch adhesive residue is expected and not a malfunction
- Oil-based removers outperform scrubbing for adhesive cleanup
- Combination oral and transdermal estradiol is a legitimate FET approach
- Skin irritation from aggressive scrubbing can complicate patch site rotation
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Kass · TikTok creator
50.7K views on this video
Replying to @lilies_and_rosegold IVF patches are no joke🤭🌈💉 #ivfgotthis #pregnancyjourney #ttcafterloss #ivfjourney #infertility #ttccommunity #fyp #ivf #pcos #miscarriageawareness #ivfmeds #ivfwarrior #ttc #ttcjourney #ivfweightloss #ivfstims #ivfbaselines #pregnancytest #frozenembryotransferjourney #infertilityjourney #infertilitycommunity #rainbowbaby #folliclescan #folliclecheck #ivftriggershots #ivfcycle1 #retrievalday #ivfretrieval #frozentransfer #transferday
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about estradiol patch adhesive residue?
Estradiol patch adhesive residue is a documented phenomenon, not a malfunction: Pastore et al. (2019) showed acrylic patch polymers resist mechanical removal.
What does the video say about oil-based products (baby oil, coconut oil, uni-solve) dissolve patch adhesive?
Oil-based products (baby oil, coconut oil, Uni-Solve) dissolve patch adhesive faster and with less skin irritation than soap-and-scrub methods.
What does the video say about oral estradiol dosed three times daily alongside a transdermal patch?
Oral estradiol dosed three times daily alongside a transdermal patch is a legitimate FET endometrial preparation approach used across reproductive clinics.
What does the video say about a 2021 cochrane review found no conclusive evidence?
A 2021 Cochrane review found no conclusive evidence that one estradiol administration route (oral vs. transdermal) produces better FET outcomes than another.
What does the video say about aggressive scrubbing at patch sites can cause skin irritation?
Aggressive scrubbing at patch sites can cause skin irritation that complicates subsequent patch placement during multi-week FET cycles.
What does the video say about this?
This is a reproductive endocrinology protocol, not testosterone therapy. Categorizing it as TRT content is a misclassification that could mislead viewers comparing their own hormone protocols.
Not medical advice. This video was made by Kass, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.